Skip to Content
listen live

PA Agrees To Deal For Inmate Hepatitis C Treatment


HARRISBURG (AP) – Pennsylvania’s prison system is moving to settle a lawsuit by agreeing to provide an expensive prescription drug for prisoners who suffer from hepatitis C infections. The Corrections Department and lawyers for thousands of inmates filed a proposed settlement this week of a 4-year-old federal class action lawsuit. The deal calls for the state to provide direct-acting anti-viral drugs, giving priority to those with the most serious conditions. The department says the average per-patient treatment cost is about $20,000. The agreement must be reviewed by prisoners who are members of the class, giving them a chance to object, before the presiding judge will decide whether to approve it. Hepatitis C is a viral infection that attacks the liver. Under the settlement, officials hope to have every affected inmate treated by mid-2022.

Comments are closed.